AwardTape · Defense awards · Research and development · Health R&D · HT942524C0038
HT942524C0038: $312K definitive contract to 60 Degrees Pharmaceuticals, Inc
60 Degrees Pharmaceuticals, Inc holds a definitive contract from Defense Health Agency with $312K obligated since Oct 2023, against a ceiling of $312K. Latest action Jul 24, 2024.
Arakoda (tafenquine) commercial packaging and validation
| PIID | HT942524C0038 |
|---|---|
| Type | definitive contract |
| Company | 60 Degrees Pharmaceuticals, Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN41 HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH |
| NAICS | 325412 PHARMACEUTICAL PREPARATION MANUFACTURING |
| Obligated since Oct 2023 | $312K |
| Total obligated (lifetime) | $312K |
| Ceiling (base and all options) | $312K |
| Base date | Jul 24, 2024 |
| Latest action | Jul 24, 2024 |
| End date | Jul 23, 2026 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Not competed |
| Place of performance | DC |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial